Trials / Unknown
UnknownNCT06156722
The Combination of Sperm Selection by IMSI and Hyaluronic Acid Binding Assay May Improve ICSI Outcome.
The Combination of Sperm Selection by IMSI and Hyaluronic Acid Binding Assay Improves ICSI Outcomes: A Randomized Prospective Sibling-oocytes Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 189 (actual)
- Sponsor
- Meir Medical Center · Academic / Other
- Sex
- Female
- Age
- 18 Years – 38 Years
- Healthy volunteers
- Accepted
Summary
In this prospective randomized sibling-oocytes blinded study, investigators examine the combination of two sperm selection methods that logically seem to complete each other, and potentially may improve ICSI outcomes. The methods include the selection of the optimal spermatozoa based on its morphology by IMSI, together with its physiological function of binding to HA by Spermslow (SS). The current study compared a group of ET after sperm selection by IMSI with SS to a group of ET after sperm selection by IMSI-only without SS, and to a mixed ET group where two embryos were transferred, one after IMSI-only and the other one after IMSI with SS.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Sperm selection by IMSI | Intracytoplasmic morphologically selected sperm injection (IMSI) is a sperm selection method used in intracytoplasmic sperm injection (ICSI) |
| PROCEDURE | Sperm selection by IMSI and spermslow | Intracytoplasmic morphologically selected sperm injection (IMSI) is a sperm selection method used in intracytoplasmic sperm injection (ICSI) + spermslow |
Timeline
- Start date
- 2019-03-01
- Primary completion
- 2024-02-01
- Completion
- 2024-02-01
- First posted
- 2023-12-05
- Last updated
- 2023-12-19
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT06156722. Inclusion in this directory is not an endorsement.